Literature DB >> 21167511

Predictors of massive transfusion with thoracic aortic procedures involving deep hypothermic circulatory arrest.

Judson B Williams1, Barbara Phillips-Bute, Syamal D Bhattacharya, Asad A Shah, Nicholas D Andersen, Burak Altintas, Brian Lima, Peter K Smith, G Chad Hughes, Ian J Welsby.   

Abstract

OBJECTIVE: Massive perioperative blood product transfusion may be required with thoracic aortic operations and is associated with poor outcomes. We analyzed independent predictors of massive transfusion in thoracic aortic surgical patients undergoing deep hypothermic circulatory arrest.
METHODS: The study consisted of 168 consecutive patients undergoing open thoracic aortic procedures involving deep hypothermic circulatory arrest between July 2005 and August 2008. We identified 26 preoperative and procedural variables as potentially related to blood product use, tested for association with total blood products transfused by multivariate linear regression model, and constructed logistic regression model for massive transfusion (requiring ≥ 5 units of transfused packed red blood cells between incision and 48 postoperative hours).
RESULTS: Multivariate linear regression determined that 6 significant variables accounted for 42% of variation in total blood products transfused: age (P = .008), preoperative hemoglobin (P = .04), weight (P = .02), cardiopulmonary bypass time (P < .0001), emergency status (P < .0001), and resternotomy (P < .0001). Final predictive logistic regression model included 1-g/dL increase in preoperative hemoglobin (odds ratio, 0.54; 95% confidence interval, 0.43-0.69; P < .0001), 10-minute increase in cardiopulmonary bypass time (odds ratio, 1.15; 95% confidence interval, 1.05-1.26; P = .0026), and emergency status (odds ratio, 4.02; 95% confidence interval, 1.53-10.55; P = .0047.
CONCLUSIONS: Cardiopulmonary bypass time, emergency status, and preoperative hemoglobin were independent predictors of massive transfusion. These variables, along with weight, age, and resternotomy, were associated with total blood product use in thoracic aortic operations involving deep hypothermic circulatory arrest.
Copyright © 2011 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21167511      PMCID: PMC3677722          DOI: 10.1016/j.jtcvs.2010.07.098

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  24 in total

1.  Preoperative haemoglobin concentration and mortality rate after coronary artery bypass surgery.

Authors:  Dlear Zindrou; Kenneth M Taylor; Jens Peder Bagger
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

2.  The independent association of massive blood loss with mortality in cardiac surgery.

Authors:  Keyvan Karkouti; Duminda N Wijeysundera; Terrence M Yau; W Scott Beattie; Esamelden Abdelnaem; Stuart A McCluskey; Mohammed Ghannam; Eric Yeo; George Djaiani; Jacek Karski
Journal:  Transfusion       Date:  2004-10       Impact factor: 3.157

3.  The platelet function defect of cardiopulmonary bypass.

Authors:  A S Kestin; C R Valeri; S F Khuri; J Loscalzo; P A Ellis; H MacGregor; V Birjiniuk; H Ouimet; B Pasche; M J Nelson
Journal:  Blood       Date:  1993-07-01       Impact factor: 22.113

4.  Preoperative disseminated intravascular coagulation associated with aortic aneurysms. A prospective study of 76 cases.

Authors:  D F Fisher; D H Yawn; E S Crawford
Journal:  Arch Surg       Date:  1983-11

5.  Coagulopathy in Ruptured or Dissecting Aortic Aneurysms.

Authors:  J W ten Cate; H Timmers; A E Becker
Journal:  Am J Med       Date:  1975-08       Impact factor: 4.965

Review 6.  Nonneurologic morbidity and profound hypothermia in aortic surgery.

Authors:  Deborah K Harrington; Jean P Lilley; Stephen J Rooney; Robert S Bonser
Journal:  Ann Thorac Surg       Date:  2004-08       Impact factor: 4.330

7.  Multivariate predictors of blood product use in cardiac surgery.

Authors:  K Gage Parr; Minalkumar A Patel; Rene Dekker; Raia Levin; Robert Glynn; Jerry Avorn; David S Morse
Journal:  J Cardiothorac Vasc Anesth       Date:  2003-04       Impact factor: 2.628

8.  Platelet consumption by arterial prostheses: the effects of endothelialization and pharmacologic inhibition of platelet function.

Authors:  L A Harker; S J Slichter; L R Sauvage
Journal:  Ann Surg       Date:  1977-11       Impact factor: 12.969

9.  Initial interactions of platelets and plasma proteins in flowing non-anticoagulated human blood with the artificial surfaces Dacron and PTFE.

Authors:  H E Roald; R M Barstad; I J Bakken; B Roald; T Lyberg; K S Sakariassen
Journal:  Blood Coagul Fibrinolysis       Date:  1994-06       Impact factor: 1.276

10.  Efficacy of FK633, an ultra-short acting glycoprotein IIb/IIIa antagonist on platelet preservation during and after cardiopulmonary bypass.

Authors:  Shigeki Tabata; Syohjiro Yamaguchi; Hiroshi Nagamine; Shigeyuki Tomita; Sadahiko Arai; Hirofumi Takemura; Go Watanabe
Journal:  Eur J Cardiothorac Surg       Date:  2004-08       Impact factor: 4.191

View more
  14 in total

1.  Outcomes of acute type a dissection repair before and after implementation of a multidisciplinary thoracic aortic surgery program.

Authors:  Nicholas D Andersen; Asvin M Ganapathi; Jennifer M Hanna; Judson B Williams; Jeffrey G Gaca; G Chad Hughes
Journal:  J Am Coll Cardiol       Date:  2014-01-08       Impact factor: 24.094

Review 2.  Decoding the volume-outcome relationship in Type A aortic dissection.

Authors:  Athanasios Antoniou; Mohamad Bashir; Amer Harky; Benjamin Adams; Rakesh Uppal
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-05-12

Review 3.  Prothrombin Complex Concentrates for Bleeding in the Perioperative Setting.

Authors:  Kamrouz Ghadimi; Jerrold H Levy; Ian J Welsby
Journal:  Anesth Analg       Date:  2016-05       Impact factor: 5.108

4.  Use of human fibrinogen concentrate during proximal aortic reconstruction with deep hypothermic circulatory arrest.

Authors:  Jennifer M Hanna; Jeffrey E Keenan; Hanghang Wang; Nicholas D Andersen; Jeffrey G Gaca; Frederick W Lombard; Ian J Welsby; G Chad Hughes
Journal:  J Thorac Cardiovasc Surg       Date:  2015-09-28       Impact factor: 5.209

5.  Results of proximal arch replacement using deep hypothermia for circulatory arrest: is moderate hypothermia really justifiable?

Authors:  Brian Lima; Judson B Williams; S Dave Bhattacharya; Asad A Shah; Nicholas Andersen; Jeffrey G Gaca; G Chad Hughes
Journal:  Am Surg       Date:  2011-11       Impact factor: 0.688

6.  Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations.

Authors:  Nicholas D Andersen; Syamal D Bhattacharya; Judson B Williams; Emil L Fosbol; Evelyn L Lockhart; Mayur B Patel; Jeffrey G Gaca; Ian J Welsby; G Chad Hughes
Journal:  Ann Thorac Surg       Date:  2012-05-01       Impact factor: 4.330

Review 7.  Massive bleeding in cardiac surgery. Definitions, predictors and challenges.

Authors:  A Petrou; P Tzimas; S Siminelakis
Journal:  Hippokratia       Date:  2016 Jul-Sep       Impact factor: 0.471

8.  Does moderate hypothermia really carry less bleeding risk than deep hypothermia for circulatory arrest? A propensity-matched comparison in hemiarch replacement.

Authors:  Jeffrey E Keenan; Hanghang Wang; Brian C Gulack; Asvin M Ganapathi; Nicholas D Andersen; Brian R Englum; Yamini Krishnamurthy; Jerrold H Levy; Ian J Welsby; G Chad Hughes
Journal:  J Thorac Cardiovasc Surg       Date:  2016-08-28       Impact factor: 5.209

9.  Predictors of electrocerebral inactivity with deep hypothermia.

Authors:  Michael L James; Nicholas D Andersen; Madhav Swaminathan; Barbara Phillips-Bute; Jennifer M Hanna; Gregory R Smigla; Michael E Barfield; Syamal D Bhattacharya; Judson B Williams; Jeffrey G Gaca; Aatif M Husain; G Chad Hughes
Journal:  J Thorac Cardiovasc Surg       Date:  2013-04-11       Impact factor: 5.209

10.  Contemporary results for proximal aortic replacement in North America.

Authors:  Judson B Williams; Eric D Peterson; Yue Zhao; Sean M O'Brien; Nicholas D Andersen; D Craig Miller; Edward P Chen; G Chad Hughes
Journal:  J Am Coll Cardiol       Date:  2012-09-05       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.